Waymo Halts Robotaxi Operations in Five US Cities After Flooding Incidents Safety Pause Extended Out of Abundance of Caution OMC Stocks in Focus After Third Fuel Price Hike in Eight Days IOC BPCL HPCL Barclays Posts 18 Profit Increase Raises FullYear Income Outlook Prediction Market Platforms Face Legal Crackdown from 16 States Nvidias 5 Trillion Market Cap Surpasses Six of Worlds Top 10 Stock Markets Amid AI Rally Jamie Dimon Signals JPMorgan Chase Could Pursue 20 Billion Acquisition Acknowledges Regulatory Hurdles VLRS Q1 2026 Earnings Narrower Loss Beats Expectations But Stock Declines ANVS Q1 2026 Earnings WiderthanExpected Loss as Pipeline Progress Continues JELDWEN Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions NMFC Q1 2026 Earnings Narrowly Misses EPS Estimates Amid Stable Operations BTCS Q1 2026 Earnings EPS Miss and Revenue Void Weigh on Shares SQM Q2 2025 Earnings EPS of 031 Reported Amid Lithium Market Headwinds Shares Rise 112 Interactive Brokers Group IBKR Faces Headwinds Stock Slides 296 Amid Sector Rotation Applovin Corporation APP Edges Lower Amid Consolidation Key Levels in Focus Nebius Group NBIS Holds Near 208 as Investors Weigh Narrow Trading Range NetSTREIT NTST Edges Lower as Consolidation Continues Near Key Support NYLI MacKay DefinedTerm Muni Opportunities Fund MMD Modest Gains Amid Stable Technical Range Apples Record Rally Faces Key Test at WWDC 2025 AI Strategy in Focus ACB Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Decline Silvercorp Metals SVM Surges 393 as Bullish Momentum Builds Toward Key Resistance Citizens Financial Group CFG Q1 2026 Earnings EPS Beat by 281 Amid Steady Performance SGRP Q4 2024 Earnings EPS Misses Estimates Amidst Undisclosed Revenue Wells Fargo Q1 2026 Earnings Slight EPS Beat Amid Steady Operating Performance Edgewell Personal Care Company EPC Q1 2026 Earnings EPS Misses Estimates Amid Cost Pressures GREEL Q1 2025 Earnings Narrower Loss Surpasses Estimates as Senior Notes Remain Stable ULH Q1 2026 Earnings A Significant Earnings Miss Amidst Operational Headwinds Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending